These results may further confirm the interactions between smoking, genetic variant of CYP1A1 and GSTM1, and promoter hypermethylation of the p16, DAPK or RARβ gene in NSCLC (Table 6). The gene discussed is GSTM1; the disease is non-small cell lung carcinoma.